MXPA03004851A - Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof. - Google Patents

Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof.

Info

Publication number
MXPA03004851A
MXPA03004851A MXPA03004851A MXPA03004851A MXPA03004851A MX PA03004851 A MXPA03004851 A MX PA03004851A MX PA03004851 A MXPA03004851 A MX PA03004851A MX PA03004851 A MXPA03004851 A MX PA03004851A MX PA03004851 A MXPA03004851 A MX PA03004851A
Authority
MX
Mexico
Prior art keywords
probiotic
therapeutic
industrial applications
compositions
preparation
Prior art date
Application number
MXPA03004851A
Other languages
Spanish (es)
Inventor
Mark Olshenitsky
Original Assignee
Bio Balance Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/725,846 external-priority patent/US6500423B2/en
Application filed by Bio Balance Corp filed Critical Bio Balance Corp
Publication of MXPA03004851A publication Critical patent/MXPA03004851A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
    • A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/84—Flavour masking or reducing agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.
MXPA03004851A 2000-11-30 2001-11-27 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof. MXPA03004851A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/725,846 US6500423B2 (en) 1999-06-03 2000-11-30 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
PCT/IL2001/001088 WO2002043649A2 (en) 2000-11-30 2001-11-27 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof

Publications (1)

Publication Number Publication Date
MXPA03004851A true MXPA03004851A (en) 2004-05-04

Family

ID=24916190

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03004851A MXPA03004851A (en) 2000-11-30 2001-11-27 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof.

Country Status (14)

Country Link
EP (1) EP1343370A4 (en)
JP (1) JP4410992B2 (en)
KR (1) KR20030082549A (en)
CN (1) CN1294253C (en)
AU (2) AU2100402A (en)
BR (1) BR0116178A (en)
CA (1) CA2430292A1 (en)
IL (1) IL156213A0 (en)
MX (1) MXPA03004851A (en)
NZ (1) NZ526748A (en)
PL (1) PL366363A1 (en)
RU (1) RU2281326C2 (en)
WO (1) WO2002043649A2 (en)
ZA (1) ZA200304747B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0212975D0 (en) * 2002-06-06 2002-07-17 Mars Uk Ltd Mammalian animal composition
IL152127A0 (en) 2002-10-06 2003-05-29 Bio Balance Corp Probiotic compositions for the treatment of inflammatory bowel disease
MXPA06001821A (en) * 2003-08-18 2006-05-31 Bio Balance Corp A stable liquid probiotic composition, preparation and applications thereof.
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
CA2652559A1 (en) * 2006-05-18 2007-11-29 Biobalance Llc Biotherapeutic compositions and uses thereof
RU2453320C2 (en) * 2008-08-05 2012-06-20 Виктор Владимирович Чалов Oral composition containing nonpathogenic microorganisms showing ability to normalise intestinal microflora (versions)
KR101127171B1 (en) * 2009-07-24 2012-03-20 (주)애드바이오텍 Composition of feed additives for ducks comprising egg yolk containing IgY against pathogen to induce acute and chronic infection disease
AU2011253984A1 (en) 2010-12-07 2012-06-28 Biobalance Llc Method For Identifying E. Coli M-17
RU2458527C1 (en) * 2010-12-30 2012-08-20 Общество с ограниченной ответственностью "БИОТРОФ" Method for production of preparation for feeding farm animals and birds and method for preparation of fodder based on it
MX363057B (en) 2012-07-20 2019-03-06 Prevtec Microbia Inc NON-PATHOGENIC F18 E. COLI</i> STRAIN AND USE THEREOF.
JP6452607B2 (en) 2012-09-25 2019-01-16 アキロン セイエレ エセ．エレ． Probiotic composition and prebiotic composition
EP4233545A3 (en) * 2012-11-23 2023-10-18 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
NZ711771A (en) 2013-02-04 2016-11-25 Seres Therapeutics Inc Compositions for treating or preventing or reducing the severity of clostridium difficile related diseases
US10973861B2 (en) 2013-02-04 2021-04-13 Seres Therapeutics, Inc. Compositions and methods
US9717726B2 (en) 2013-03-14 2017-08-01 Maregade Rx, LLC Product and method for treating diarrhea
US10076546B2 (en) 2013-03-15 2018-09-18 Seres Therapeutics, Inc. Network-based microbial compositions and methods
KR102515850B1 (en) 2013-11-25 2023-03-30 세레스 테라퓨틱스, 인코포레이티드 Synergistic bacterial compositions and methods of production and use thereof
WO2015095241A2 (en) 2013-12-16 2015-06-25 Seres Health, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
RU2660355C2 (en) * 2016-04-01 2018-07-05 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Antibacterial pharmaceutical composition for oral use containing bacteriophages
MX2018015588A (en) * 2016-06-14 2019-04-11 Prevtec Microbia Inc Animal feed pellets including a feed additive, method of making and of using same.
RU2639544C1 (en) * 2016-12-16 2017-12-21 Общество с ограниченной ответственностью "БИОРЕАКТОР" Means for treatment and prevention of bird gastrointestinal tract diseases
EP3558296B1 (en) 2016-12-23 2023-06-28 Maregade RX, LLC Low dose product and method for treating diarrhea
CN107319103A (en) * 2017-08-01 2017-11-07 河南牧业经济学院 Promote feed addictive of growth of animals or poultry and intestinal growth and its preparation method and application
EP3668527A1 (en) 2017-08-14 2020-06-24 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease
KR101939080B1 (en) * 2017-10-23 2019-01-16 고려대학교 산학협력단 Pseudomonas veronii strain KACC 81051BP and composition for comprising the same
CN109260235A (en) * 2018-10-23 2019-01-25 上海市第十人民医院 A kind of application of composition in preparation prevention and treatment constipation drug or health care product
CN110004072B (en) * 2018-11-12 2021-08-13 西安交通大学 Probiotic enterococcus faecalis isolate A3-1 and application thereof
CN113652340A (en) * 2021-08-24 2021-11-16 江苏江大源生态生物科技股份有限公司 Probiotic preparation, strain screening device and screening method
CN113616715B (en) * 2021-08-31 2022-05-06 昆明理工大学 Fermented traditional Chinese medicine oral liquid for treating piglet diarrhea and improving intestinal flora thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3908028A (en) * 1973-04-19 1975-09-23 Procter & Gamble Soft drink composition containing paramethoxycinnamaldehyde as a flavoring agent and sweetner
GB1501098A (en) * 1974-06-11 1978-02-15 Brewing Patents Ltd Preparation of hop oil
US4986985A (en) * 1987-11-02 1991-01-22 Bar Ilan University Method of treating skin virus infections
CH675685A5 (en) * 1988-06-24 1990-10-31 Flachsmann Ag Emil
US5443826A (en) * 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
US5082489A (en) * 1990-02-06 1992-01-21 The Royal Institution For The Advancement Of Learning (Mcgill University) Composition for biocontrol of wild buckwheat
US5478557A (en) * 1992-07-29 1995-12-26 The United States Of America, As Represented By The Secretary Of Agriculture Probiotic for control of salmonella
US5486367A (en) * 1992-10-13 1996-01-23 Kansas State University Research Foundation Enzymatic method for accelerating fermentation of comestible products
US5376374A (en) * 1993-05-24 1994-12-27 Zelaya; Luz M. Oral rinse composition
US5733774A (en) * 1995-02-02 1998-03-31 Ecoscience Corporation Method and composition for producing stable bacteria and bacterial formulations
AU714310B2 (en) * 1995-05-12 1999-12-23 Japan Pharmaceutical Development Co., Ltd Plant extract
DK0828502T3 (en) * 1995-05-26 2002-04-15 D & W Trading B V Pharmaceutical compositions based on essential oils obtained from plants for use in the field of human and veterinary medicine
US5679364A (en) * 1995-06-07 1997-10-21 Lee County Mosquito Control District Compositions and methods for reducing the amount of contaminants in aquatic and terrestrial environments
GB2303799B (en) * 1995-07-29 1999-03-10 Siemens Plc Improvements in or relating to aqueous sample testing apparatus
US5888395A (en) * 1996-08-30 1999-03-30 The Regents Of The University Of California Method for enhanced longevity of in situ microbial filter used for bioremediation
US5773075A (en) * 1996-12-13 1998-06-30 Kalamazoo Holdings, Inc. High temperature countercurrent solvent extraction of Capsicum solids
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
IL130303A0 (en) * 1999-06-03 2000-06-01 M G Novobiotech Ltd A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use

Also Published As

Publication number Publication date
BR0116178A (en) 2003-10-14
EP1343370A4 (en) 2004-02-11
CN1294253C (en) 2007-01-10
ZA200304747B (en) 2004-09-03
RU2281326C2 (en) 2006-08-10
AU2100402A (en) 2002-06-11
JP2004534512A (en) 2004-11-18
CN1494374A (en) 2004-05-05
CA2430292A1 (en) 2002-06-06
IL156213A0 (en) 2003-12-23
JP4410992B2 (en) 2010-02-10
WO2002043649A8 (en) 2004-04-29
WO2002043649A2 (en) 2002-06-06
AU2002221004B2 (en) 2007-01-25
EP1343370A2 (en) 2003-09-17
NZ526748A (en) 2006-03-31
PL366363A1 (en) 2005-01-24
KR20030082549A (en) 2003-10-22
WO2002043649A3 (en) 2002-08-29

Similar Documents

Publication Publication Date Title
MXPA03004851A (en) Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof.
IL130303A0 (en) A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use
GR970300016T1 (en) Lactobacillus strains of human origin, their compositions and uses thereof
PL348973A1 (en) Oral administration of lactobacillus for the treatment and prevention of urogenital infection
BG103967A (en) Medicinal herb composition extract and method with immunointensificationb ability
MY116272A (en) Immunity enhancing lactic acid bacteria
AU2002316982A1 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
AU1870099A (en) Stabilised insulin compositions
MXPA02010982A (en) Fractionation and processing of oilseed meal.
MY133372A (en) Foods comprising a gel composition and process of manufacture
AU6160200A (en) New bifidobacteria preventing diarrhea caused by pathogenic bacteria
AU2003293555A1 (en) 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
Thanish Ahamed et al. Antibacterial activity of taxifolin isolated from acacia catechu leaf extract–An in vitro study
AU4721399A (en) Methods and compositions for improving aerobic stability of silage
PL355620A1 (en) Method for drying bacteria
MY130792A (en) 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES
EP1238587A3 (en) Biopesticide compositions
TR200200300T2 (en) Bifidobacteria suitable for preventing diarrhea.
DE60030786D1 (en) MURRAYA KOENIGII EXTRACTS FOR THE TREATMENT OF ASTHMA
TW200503687A (en) Water-soluble isoflavon composition, manufacture method and usage thereof
WO2022079261A3 (en) Use of microorganisms and calcium for improved plant health and/or resilience against plant pathogens
MD20010055A (en) Microbial sanogenic preparation for prevention and treatment of intestinal disbacteriosis

Legal Events

Date Code Title Description
FA Abandonment or withdrawal